Fenspiride
Systematic (IUPAC) name | |
---|---|
8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one | |
Clinical data | |
Trade names | Eurespal, Pneumorel |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration | Oral |
Pharmacokinetic data | |
Bioavailability | 90%[1] |
Biological half-life | 14–16 hours |
Excretion | Urine (90%), feces (~10%) |
Identifiers | |
CAS Number | 5053-06-5 |
ATC code | R03BX01 R03DX03 |
PubChem | CID 68626 |
DrugBank | DB08979 |
ChemSpider | 3227 |
UNII | S983QC7HKM |
KEGG | D07949 |
ChEMBL | CHEMBL576127 |
Chemical data | |
Formula | C15H20N2O2 |
Molar mass | 260.331 g/mol |
| |
| |
(what is this?) (verify) |
Fenspiride (INN, brand names Eurespal, Pneumorel and others) is an oxazolidinone spiro compound used as a drug in the treatment of certain respiratory diseases.[2] The pharmacotherapeutic classification is antitussives. In Russia it is approved for the treatment of acute and chronic inflammatory diseases of ENT organs (ear, nose, throat) and the respiratory tract (like rhinopharyngitis, laryngitis, tracheobronchitis, otitis and sinusitis), as well as for maintenance treatment of asthma.[3]
References
- ↑ Montes, B; Catalan, M; Roces, A; Jeanniot, JP; Honorato, JM (1993). "Single dose pharmacokinetics of fenspiride hydrochloride: phase I clinical trial.". European journal of clinical pharmacology 45 (2): 169–72. doi:10.1007/bf00315501. PMID 7901024.
- ↑ Płusa T, Nawacka D (Dec 1998). "Efficacy and tolerance of fenspiride in adult patients with acute respiratory tract infections". Pol Merkur Lekarski 5 (30): 368–71. PMID 10101527.
- ↑ "Эреспал® (Eurespal®) Prescribing Information. VIDAL Drug Compendium" (in Russian). Retrieved 6 February 2014.
|
This article is issued from Wikipedia - version of the Friday, October 09, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.